Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Cipla signs licensing deal with Lilly to manufacture and commercialise baricitinib in India
Baricitinib was issued a restricted emergency use approval by CDSCO to treat COVID-19
A masterstroke needed from the PM to accelerate Universal COVID-19 vaccination – A letter to the PM
Chandru Chawla, a pharma industry veteran, writes an open letter to the Prime Minister of India on the immediate steps and radical…
Tech transfers, collaborations, materials supply key to scale up vaccine manufacturing: Suchitra…
Bharat Biotech is in the process of ramping up the manufacturing capacity of Covaxin to 70 crore dosages per annum
Ajanta Pharma lines up CAPEX of Rs 250 crores for current fiscal
It will largely go towards maintenance and some new expansions for the corporate office and some key expansions in the facility,…
Beyond the pandemic: Building collaborative media engagement for clinical research
Melissa Arulappan, Head, Corporate Communications, IQVIA India elaborates on the learnings for journalists from the pandemic to…
India will study claim of Sputnik Light: Dr VK Paul
He was responding to a query if Sputnik Light will be used in India for vaccinating its population against the infection
DCGI nod for anti-COVID 19 drug developed by DRDO
Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental…
Biological E. to begin Phase III trial of COVID-19 vaccine
The company plans to produce 75 million to 80 million doses a month from August
Roche’s antibody cocktail for COVID-19 may face affordability issues in India: GlobalData
Considering that it is a combination of two recombinant human immunoglobulin G-1 (IgG1) monoclonal antibodies, it is expected to…
Mankind Pharma collaborates with Accenture for digital transformation with data-driven cloud…
Redesigns business processes and develops and deploys a digital platform to improve operational performance across its global…